本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aerovate Therapeutics, Inc.

9.80
0.0000
成交量:- -
成交额:276.85万
市值:2.84亿
市盈率:-5.76
高:9.80
开:9.80
低:9.80
收:9.80
52周最高:884.98
52周最低:9.80
股本:2,898.50万
流通股本:1,196.45万
量比:- -
换手率:- -
股息:2.40
股息率:24.49%
每股收益(TTM):-1.7025
每股收益(LYR):-2.4361
净资产收益率:-59.01%
总资产收益率:-36.18%
市净率:3.79
市盈率(LYR):-4.02

数据加载中...

2025/04/30

重要事件披露

Form 8-K - Current report
2025/04/25

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/23

重要事件披露

Form 8-K - Current report
2025/04/21

重要事件披露

Form 8-K - Current report
2025/04/09

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/04/09

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/04/09

重要事件披露

Form 8-K - Current report
2025/04/09

重要事件披露

Form 8-K - Current report
2025/04/09

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/04/07

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/04/07

重要事件披露

Form 8-K - Current report
2025/04/07

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/26

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/03/04

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/02/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/02/04

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/24

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/13

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/11/18

企业合并公告

Form 425 - Prospectuses and communications, business combinations